Treatment of Infections Caused by Ampicillin-Resistant Pathogens with a Combination of Ampicillin and CP-45,899
Open Access
- 1 March 1982
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 21 (3) , 519-520
- https://doi.org/10.1128/aac.21.3.519
Abstract
Eleven patients infected with ampicillin-resistant organisms were treated with a combination of CP-45,899, a β-lactamase inhibitor, and ampicillin. All infections were controlled within 7 days without any signs of toxicity.This publication has 4 references indexed in Scilit:
- CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and BacteroidesAntimicrobial Agents and Chemotherapy, 1980
- Comparative Inhibition of β-Lactamases by Novel β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979
- CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological CharacterizationAntimicrobial Agents and Chemotherapy, 1978
- Interaction of Clindamycin and Gentamicin In VitroAntimicrobial Agents and Chemotherapy, 1974